Restart Life Sciences Corp.

CNSX:HEAL Stock Report

Market Cap: CA$1.1m

Restart Life Sciences Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Steve Loutskou

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership2.6%
Management average tenureno data
Board average tenure3.5yrs

Recent management updates

Recent updates

This Is Why Nova Mentis Life Science Corp.'s (CSE:NOVA) CEO Compensation Looks Appropriate

Dec 09
This Is Why Nova Mentis Life Science Corp.'s (CSE:NOVA) CEO Compensation Looks Appropriate

We Think Nova Mentis Life Science (CSE:NOVA) Can Afford To Drive Business Growth

Dec 07
We Think Nova Mentis Life Science (CSE:NOVA) Can Afford To Drive Business Growth

CEO

Steve Loutskou

less than a year

Tenure

Mr. Steve Loutskou is President and Chief Executive Officer of Restart Life Sciences Corp. (formerly known as Nova Mentis Life Science Corp.) from October 22, 2024. He is Director of Restart Life Sciences...

Board Members

NamePositionTenureCompensationOwnership
Steve Loutskou
Presidentless than a yearno data2.56%
CA$ 27.7k
Marvin Hausman
Chairman of Scientific Advisory Board4.1yrsno datano data
Georg Hochwimmer
Director1.1yrsno datano data
Kyle Ambert
Member of Scientific Advisory Board4yrsno datano data
Julia Perederiy
Member of Scientific Advisory Board4yrsno datano data
Gary Harlem
Member of Scientific Advisory Board3.9yrsno datano data
John Molinaro
Member of Scientific Advisory Board3yrsno datano data
Viviana Trezza
Member of Scientific Advisory Boardno datano datano data
Khavita Harrycharran
Directorless than a yearno datano data

3.5yrs

Average Tenure

Experienced Board: HEAL's board of directors are considered experienced (3.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/04 07:54
End of Day Share Price 2024/12/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Restart Life Sciences Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution